MENU

News Release

News Release

NEWS RELEASE

News Release

Initiation of Phase I-IIa Clinical Trial of Antibody-inducing Peptide FPP003

Shionogi and FunPep Conclude Joint Research Agreement on Antibody-Inducing Peptides

Announcement of Fund Raising through Third Party Allocation of New Shares

Submission of a Phase II Clinical Trial Plan for Functional Peptide SR-0379

Announce of Conclusion of Option Agreement with Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma and FunPep Conclude Joint Research Agreement on Antibody-Inducing Peptides